Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers April 22, 2019
Pharmacy Choice - Pharmaceutical News - CVS Health Corporation (CVS) Analysts See $1.40 EPS on May, 1 [Gulf Daily News (Bahrain)] - April 22, 2019

Pharmacy News Article

 4/16/18 - CVS Health Corporation (CVS) Analysts See $1.40 EPS on May, 1 [Gulf Daily News (Bahrain)]

Big Money Sentiment decreased to 0.72 in 2017 Q4. It has change of 0.16, from 2017Q3s 0.88. The ratio worsened due to CVS Health Corporation positioning: 115 sold and 600 reduced. 134 funds amassed positions and 380 increased positions. Investors holded 801.45 million in 2017Q3 but now own 815.59 million shares or 1.76% more.

Truepoint Incorporated, Ohio-based fund reported 43,512 shs. Baystate Wealth Mngmt Limited Liability Company has 0.02% invested in CVS Health Corporation (NYSE:CVS). Atlantic Trust Group Ltd Company stated it has 1.35M shs or 0.42% of all its holdings. Brinker Inc invested in 0.25% or 90,042 shs. Amica Mutual Insurance owns 40,344 shs. Lord Abbett And Ltd stated it has 0.32% in CVS Health Corporation (NYSE:CVS). Vanguard Grp has invested 0.25% in CVS Health Corporation (NYSE:CVS). Legacy Private holds 42,094 shs. Waddell & Reed Finance holds 0.12% or 732,969 shs. Birch Hill Invest Advsr Limited Co accumulated 46,821 shs. Advsrs Limited Co holds 16,038 shs or 0.08% of its capital. Whitnell holds 1.46% or 48,158 shs in its capital. Alps Advisors holds 6,275 shs or 0% of its capital. Bright Rock Cap Mngmt Ltd Liability Co holds 2.18% or 111,000 shs in its capital. Yhb Advisors invested in 90,500 shs or 1.12% of the stock.

CVS Health Corporation had 1 insider sale and 0 insider buys since February 16, 2018. Thiss net activity of $1.42 million.

CVS Health Corporation (NYSE:CVS)s earnings release is anticipated by WallStreet on May, 1, RTT reports. The EPS diference is $0.23 or 19.66 % up from last years number. Previous year: $1.17; Analysts forcast: $1.40. If $1.40 is reported, CVSs profit will hit $1.42B for 11.33 P/E. After $1.92 EPS report last quarter, Wall Street now predicts -27.08 % negative EPS growth of CVS Health Corporation. The stock decreased 0.89% or $0.57 during the last trading session, reaching $63.43.Currently CVS Health Corporation is downtrending after 22.81% change in last April 15, 2017. CVS has also 5.83 million shares volume. The stock underperformed the S&P 500 by 34.36%.

CVS Health Corporation (NYSE:CVS) Ratings Coverage

Total analysts of 14 have positions in CVS Health (NYSE:CVS) as follows: 10 rated it a Buy, 0 with Sell and 4 with Hold. The positive are 71%. Since October 18, 2017 according to StockzIntelligence Inc CVS Health has 30 analyst reports. On Thursday, January 4 SunTrust maintained CVS Health Corporation (NYSE:CVS) with Buy rating. On Thursday, February 8 RBC Capital Markets maintained CVS Health Corporation (NYSE:CVS) rating. RBC Capital Markets has Buy rating and $89.0 target. In Tuesday, November 21 report Leerink Swann maintained the stock with Buy rating. In Tuesday, November 7 report Loop Capital maintained the stock with Hold rating. In Tuesday, January 2 report Needham maintained the stock with Buy rating. On Tuesday, November 7 Jefferies maintained CVS Health Corporation (NYSE:CVS) rating. Jefferies has Hold rating and $76 target. On Tuesday, December 26 the stock has Buy rating by Tigress Financial. On Friday, October 27 the stock has Hold rating by Robert W. Baird. On Monday, December 4 the stock of CVS Health Corporation (NYSE:CVS) has Buy rating given by Needham. On Thursday, January 4 Robert W. Baird maintained the shares of CVS in report with Hold rating.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services.The firm is worth $64.41 billion. It operates through Pharmacy Services and Retail/LTC divisions.The P/E ratio is 9.85. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

(c) 2018 Al Hilal Publishing and Marketing Group Provided by SyndiGate Media Inc. (

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Apr 23: Management of Bipolar Disorder
Last Chance
Apr 24: Identifying, Targeting and Managing Chronic Renal Failure
Apr 25: COPD Update for Pharmacy Professionals
Apr 28: Pharmacy & the Opioid Crisis
Apr 29: Headache Disorders: Focus on Common Migraines & Tension Headaches
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement